Pharmacy order for patient medication - baltimore VA medical center.
Ended Awarded Last action
- Contract number
- 36C24526N0551
- Awardee
-
Bristol-Myers Squibb Company UEI UFGKB2B71N12
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $6,164
Award facts
- Contract value 100% obligated
- $6,163.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Memphis, TN 38141, USA
Award details come from SAM.gov/FPDS.
About this award
Bristol-Myers Squibb Company, a global biopharmaceutical manufacturer specializing in oncology and immunotherapy products, has been awarded a pharmacy order delivery under its Federal Supply Schedule contract (36F79724D0101) with the Department of Veterans Affairs, Veterans Integrated Service Network 5. This firm fixed-price delivery order, valued at $6,163.72, was issued on April 27, 2026, with a completion date of April 28, 2026, and will support medication fulfillment for the Baltimore VA Medical Center. The order is being fulfilled through Bristol-Myers Squibb's facility in Memphis, Tennessee, and represents a call against the company's Pharmaceuticals and Drugs (FSS-61-IB) master supply schedule contract, which carries a substantial ceiling value of $12.3 billion and extends through April 30, 2029.
This delivery order continues Bristol-Myers Squibb's established role as a critical pharmaceutical supplier to the Department of Veterans Affairs, providing access to the company's specialized oncology and cell therapy products, including CAR T-cell therapies such as BREYANZI and ABECMA, along with other specialty oncology pharmaceuticals. The award carries no small business set-aside designation, reflecting Bristol-Myers Squibb's status as a large pharmaceutical manufacturer. The underlying Federal Supply Schedule contract has generated more than fifty documented delivery orders to support the VA healthcare system's oncology and specialized immunotherapy treatment requirements since 2022, demonstrating sustained demand for advanced cancer treatments that represent the current standard of care for eligible veterans.
Quick answers
Who was awarded contract 36C24526N0551?
36C24526N0551 was awarded to Bristol-Myers Squibb Company by Veterans Integrated Service Network 5 (Veterans Health Administration) on April 27, 2026.
How much is contract 36C24526N0551 worth?
The government has obligated $6,164 on 36C24526N0551.
Is contract 36C24526N0551 an order under another contract?
Yes. 36C24526N0551 is a BPA call under 36F79724D0101-36E79726A0010, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24526N0551 competed?
The extent of competition for 36C24526N0551 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award